News25/Ratings0
News · 26 weeks63+33%
2026-03-012026-08-23
Mix3590d
- SEC Filings16(46%)
- Insider11(31%)
- Other8(23%)
Latest news
25 items- SECProfusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- SECProfusa Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- PRProfusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics CompanyDebt and liabilities holders have executed $10.7 million of Series A Convertible Exchange Agreements; of which $4.57 million was converted into Series A Convertible Preferred Stock Sufficient working capital obtained to fund operations for near term PCAOB audited 2024 and 2025 financials of G3 and Subsidiaries are expected by mid-September Reverse stock split successfully executed August 20, 2026 BERKELEY, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensor technologies, previously announced the signing of an Option Agreement (the "Agreement") which provides Profusa the right and option, but not the obli
- INSIDERChief Financial Officer Knechtel Fred S. converted options into 301,991 shares (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERChief Executive Officer Stover Jack E converted options into 301,991 shares (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- SECSEC Form 10-Q filed by Profusa Inc.10-Q - Profusa, Inc. (0001859807) (Filer)
- INSIDERLarge owner Hrt Financial Lp sold $109,266 worth of shares (18,395 units at $5.94), closing all direct ownership in the company (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- SECSEC Form PRE 14A filed by Profusa Inc.PRE 14A - Profusa, Inc. (0001859807) (Filer)
- INSIDERLarge owner Hrt Financial Lp sold $2,853 worth of shares (3,163 units at $0.90), decreasing direct ownership by 4% to 71,035 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERLarge owner Hrt Financial Lp bought $5,384 worth of shares (5,585 units at $0.96) and sold $37,661 worth of shares (42,411 units at $0.89), decreasing direct ownership by 33% to 74,198 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- SECProfusa Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- PRProfusa Announces 1-for-4 Reverse Stock SplitBERKELEY, California, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a one-for-four (1:4) reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on August 17, 2026, and the Company’s common stock will open for trading on The Nasdaq Capital Market on August 17, 2026 on a post-split
- INSIDERLarge owner Hrt Financial Lp bought $3,791 worth of shares (4,016 units at $0.94) and sold $2,212 worth of shares (2,280 units at $0.97), increasing direct ownership by 2% to 111,024 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERLarge owner Hrt Financial Lp sold $1,235 worth of shares (1,307 units at $0.94) and bought $873 worth of shares (926 units at $0.94), decreasing direct ownership by 0.35% to 109,288 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERLarge owner Hrt Financial Lp bought $15,250 worth of shares (15,924 units at $0.96), increasing direct ownership by 17% to 109,669 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERLarge owner Hrt Financial Lp bought $10,325 worth of shares (9,874 units at $1.05), increasing direct ownership by 12% to 93,745 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- PRProfusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision LabsBERKELEY, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensing technologies, announces the signing of an Option Agreement (the "Agreement") which provides Profusa the right and option, but not the obligation, subject to satisfaction of the conditions described below, to acquire G3 Vision Labs, Inc. ("G3") and its subsidiaries, Med Screen Laboratories Inc., Dominion Diagnostics LLC and Acutis Diagnostics Inc. G3's 2025 Net Revenues are estimated, based on unaudited management information, to be approximately $111 million. The Agreement formalizes the arrangement between Profusa and G3 that was announced earlie
- SECProfusa Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- INSIDERLarge owner Hrt Financial Lp bought $1,323 worth of shares (1,310 units at $1.01), increasing direct ownership by 2% to 83,871 units (SEC Form 4)4 - Profusa, Inc. (0001859807) (Issuer)
- INSIDERNew insider Hrt Financial Lp claimed ownership of 82,561 shares (SEC Form 3)3 - Profusa, Inc. (0001859807) (Issuer)
- SECProfusa Inc. filed SEC Form 8-K: Leadership Update, Other Events, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Profusa, Inc. (0001859807) (Filer)
- PRProfusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics CompanyBERKELEY, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensing technologies, announces the signing of a non-binding term sheet with a privately held, commercial-stage health diagnostics and toxicology testing company (the "Dx Company"). Following the contemplated transaction, the combined company is expected to operate as a public diagnostics company with national CLIA-certified laboratories, recurring revenues from a diversified base of providers serving addiction treatment, pain management, and behavioral health. The Dx Company’s 2025 Net Revenues are estimated, based on unaudited management information, to
- SECSEC Form 424B3 filed by Profusa Inc.424B3 - Profusa, Inc. (0001859807) (Filer)
- SECSEC Form 424B3 filed by Profusa Inc.424B3 - Profusa, Inc. (0001859807) (Filer)
- SECSEC Form 424B3 filed by Profusa Inc.424B3 - Profusa, Inc. (0001859807) (Filer)
PFSA FAQ
4 questionsWhere does PFSA stock trade?
Profusa Inc. (PFSA) is listed on NASDAQ.What sector and industry is PFSA in?
Profusa Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to PFSA?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare PFSA side-by-side with any of them on Quantisnow.How can I track PFSA on Quantisnow?
Quantisnow aggregates Profusa Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PFSA to receive live email and push alerts on every new disclosure.